risedronic acid has been researched along with Cystic Fibrosis in 1 studies
Risedronic Acid: A pyridine and diphosphonic acid derivative that acts as a CALCIUM CHANNEL BLOCKER and inhibits BONE RESORPTION.
Cystic Fibrosis: An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haworth, CS | 1 |
| Sharples, L | 1 |
| Hughes, V | 1 |
| Elkin, SL | 1 |
| Hodson, ME | 1 |
| Conway, SP | 1 |
| Etherington, C | 1 |
| Elborn, JS | 1 |
| Rendall, J | 1 |
| Wheaton, E | 1 |
| Kadri, E | 1 |
| Elliott, J | 1 |
| Barker, HC | 1 |
| Bearcroft, PW | 1 |
| Hlaing, T | 1 |
| Compston, JE | 1 |
1 trial available for risedronic acid and Cystic Fibrosis
| Article | Year |
|---|---|
Multicentre trial of weekly risedronate on bone density in adults with cystic fibrosis.
Topics: Adult; Bone Density; Bone Density Conservation Agents; Cystic Fibrosis; Drug Administration Schedule | 2011 |